Promino Nutritional Sciences Inc. (MUSL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 29 | 34 | 82 | 154 |
| Accounts receivable | -111 | 826 | -476 | 198 | -350 |
| Accounts payable and accrued liabilities | -776 | 1,160 | N/A | N/A | N/A |
| Other Working Capital | -1,231 | 2,579 | 4,179 | -2,813 | 1,004 |
| Other Operating Activity | -3,506 | -6,388 | -8,242 | -7,409 | -2,961 |
| Operating Cash Flow | $-5,623 | $-1,794 | $-4,506 | $-9,942 | $-2,152 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 1 | -20 | -37 | -10 |
| Sale Of Investment | 474 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 1,869 | 0 | 0 | 0 | 1,858 |
| Investing Cash Flow | $2,342 | $1 | $-20 | $-37 | $1,848 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -310 | N/A | 481 | -281 | 365 |
| Debt Issued | 0 | 1,930 | 400 | 0 | 40 |
| Debt Repayment | 0 | -207 | -3 | -317 | -184 |
| Common Stock Issued | 3,731 | 0 | 3,500 | 12,123 | 0 |
| Other Financing Activity | 0 | 0 | -85 | -976 | 0 |
| Financing Cash Flow | $3,422 | $1,723 | $4,294 | $10,549 | $221 |
| Exchange Rate Effect | 5 | 67 | -263 | -165 | 66 |
| Beginning Cash Position | 1 | 3 | 492 | 87 | 105 |
| End Cash Position | 147 | 1 | 3 | 492 | 87 |
| Net Cash Flow | $141 | $-70 | $-226 | $569 | $-84 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,623 | -1,794 | -4,506 | -9,942 | -2,152 |
| Capital Expenditure | N/A | N/A | -23 | -37 | -10 |
| Free Cash Flow | -5,623 | -1,794 | -4,529 | -9,979 | -2,162 |